STXBP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.88178419700125E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.41628980449605E-14 |
Normal-vs-Stage2 |
2.235900E-04 |
Normal-vs-Stage3 |
1.65312208366686E-13 |
Normal-vs-Stage4 |
1.62436730732907E-12 |
Stage1-vs-Stage2 |
6.609800E-01 |
Stage1-vs-Stage3 |
3.934200E-02 |
Stage1-vs-Stage4 |
2.517300E-03 |
Stage2-vs-Stage3 |
1.604780E-01 |
Stage2-vs-Stage4 |
7.323800E-02 |
Stage3-vs-Stage4 |
5.483200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63091762317435E-12 |
Normal-vs-AfricanAmerican |
1.12290177156638E-11 |
Normal-vs-Asian |
7.999500E-03 |
Caucasian-vs-AfricanAmerican |
5.855000E-01 |
Caucasian-vs-Asian |
6.715400E-01 |
AfricanAmerican-vs-Asian |
4.524400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.66133814775094E-16 |
Normal-vs-Female |
6.26021456895387E-12 |
Male-vs-Female |
3.127600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.21849999984636E-08 |
Normal-vs-Age(41-60Yrs) |
9.68780611287912E-13 |
Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
Normal-vs-Age(81-100Yrs) |
2.18910000016059E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.431200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.854800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.160200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.527200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.535000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.947800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.162100E-02 |
Normal-vs-Grade 2 |
2.33999997156786E-09 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
1.812040E-01 |
Grade 1-vs-Grade 3 |
1.078820E-03 |
Grade 1-vs-Grade 4 |
1.53846999999541E-05 |
Grade 2-vs-Grade 3 |
7.004100E-04 |
Grade 2-vs-Grade 4 |
3.4805999971077E-08 |
Grade 3-vs-Grade 4 |
7.234300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.12489999724164E-08 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
1.88469999995444E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.45612427565811E-13 |
Normal-vs-N1 |
1.26720000048763E-08 |
N0-vs-N1 |
2.824400E-02 |
|
|